ID   PA2GX_RAT               Reviewed;         151 AA.
AC   Q9QZT3;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JAN-2024, entry version 140.
DE   RecName: Full=Group 10 secretory phospholipase A2;
DE            EC=3.1.1.4 {ECO:0000250|UniProtKB:O15496};
DE   AltName: Full=Group X secretory phospholipase A2;
DE            Short=GX sPLA2;
DE            Short=sPLA2-X;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 10;
DE   Flags: Precursor;
GN   Name=Pla2g10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10531313; DOI=10.1074/jbc.274.44.31195;
RA   Valentin E., Ghomashchi F., Gelb M.H., Lazdunski M., Lambeau G.;
RT   "On the diversity of secreted phospholipases A2. Cloning, tissue
RT   distribution, and functional expression of two novel mouse group II
RT   enzymes.";
RL   J. Biol. Chem. 274:31195-31202(1999).
CC   -!- FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily
CC       targets extracellular phospholipids. Hydrolyzes the ester bond of the
CC       fatty acyl group attached at sn-2 position of phospholipids with
CC       preference for phosphatidylcholines and phosphatidylglycerols over
CC       phosphatidylethanolamines. Preferentially releases sn-2 omega-6 and
CC       omega-3 polyunsaturated fatty acyl (PUFA) chains over saturated fatty
CC       acyls. Contributes to phospholipid remodeling of very low-density
CC       lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density
CC       lipoprotein (HDL) particles. Hydrolyzes LDL phospholipids releasing
CC       unsaturated fatty acids that regulate macrophage differentiation toward
CC       foam cells. Efficiently hydrolyzes and inactivates platelet activating
CC       factor (PAF), a potent lipid mediator present in oxidized LDL (By
CC       similarity). May act in an autocrine and paracrine manner. Secreted by
CC       lung epithelium, targets membrane phospholipids of infiltrating
CC       eosinophils, releasing arachidonate and boosting eicosanoid and
CC       cysteinyl leukotriene synthesis involved in airway inflammatory
CC       response. Secreted by gut epithelium, hydrolyzes dietary and biliary
CC       phosphatidylcholines in the gastrointestinal lumen. Plays a stem cell
CC       regulator role in colon epithelium. Within intracellular compartment,
CC       mediates Paneth-like cell differentiation and its stem cell supporting
CC       functions by inhibiting the Wnt signaling pathway in intestinal stem
CC       cell (ISC). Secreted in the intestinal lumen upon inflammation, acts in
CC       an autocrine way and promotes prostaglandin E2 synthesis that
CC       stimulates Wnt signaling pathway in ISCs and tissue regeneration. May
CC       participate in hair follicle morphogenesis by regulating
CC       phosphatidylethanolamines metabolism at the outermost epithelial layer
CC       and facilitating melanin synthesis. By releasing
CC       lysophosphatidylcholines (LPCs) at sperm acrosome, controls sperm cell
CC       capacitation, acrosome reaction and overall fertility. May promote
CC       neurite outgrowth in neuron fibers involved in nociception (By
CC       similarity). Contributes to lipid remodeling of cellular membranes and
CC       generation of lipid mediators involved in pathogen clearance. Cleaves
CC       sn-2 fatty acyl chains of phosphatidylglycerols and
CC       phosphatidylethanolamines, which are major components of membrane
CC       phospholipids in bacteria. Displays bactericidal activity against Gram-
CC       positive bacteria by directly hydrolyzing phospholipids of the
CC       bacterial membrane. In pulmonary epithelium, may contribute to host
CC       defense response against adenoviral infection. Prevents adenovirus
CC       entry into host cells by hydrolyzing host cell plasma membrane,
CC       releasing C16:0 LPCs that inhibit virus-mediated membrane fusion and
CC       viral infection. Likely prevents adenoviral entry into the endosomes of
CC       host cells (By similarity). May play a role in maturation and
CC       activation of innate immune cells including macrophages, group 2 innate
CC       lymphoid cells and mast cells (By similarity).
CC       {ECO:0000250|UniProtKB:O15496, ECO:0000250|UniProtKB:Q9QXX3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000250|UniProtKB:O15496, ECO:0000255|PROSITE-
CC         ProRule:PRU10035, ECO:0000255|PROSITE-ProRule:PRU10036};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         octadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40519, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73858, ChEBI:CHEBI:74965;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40520;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoglycerol + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphoglycerol + H(+); Xref=Rhea:RHEA:44524,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:84472, ChEBI:CHEBI:84475;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44525;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) + H2O
CC         = 1-hexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:45472, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:72829,
CC         ChEBI:CHEBI:75158; Evidence={ECO:0000250|UniProtKB:Q9QXX3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45473;
CC         Evidence={ECO:0000250|UniProtKB:Q9QXX3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-
CC         serine + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phospho-L-serine + H(+); Xref=Rhea:RHEA:41752, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:75020,
CC         ChEBI:CHEBI:75029; Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41753;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40815, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:73004, ChEBI:CHEBI:73008;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40816;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate +
CC         H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-phosphate +
CC         H(+); Xref=Rhea:RHEA:63996, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:57518, ChEBI:CHEBI:64839;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63997;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         O-hexadecyl-sn-glycero-3-phosphocholine + acetate + H(+);
CC         Xref=Rhea:RHEA:40479, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30089, ChEBI:CHEBI:44811, ChEBI:CHEBI:64496;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40480;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:O15496};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250|UniProtKB:O15496};
CC   -!- SUBUNIT: Interacts with PLA2R1; this interaction mediates PLA2G10
CC       clearance and inactivation. {ECO:0000250|UniProtKB:Q9QXX3}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9QXX3}. Lysosome
CC       {ECO:0000250|UniProtKB:Q9QXX3}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000250|UniProtKB:Q9QXX3}.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF166100; AAF04501.1; -; mRNA.
DR   RefSeq; NP_058872.1; NM_017176.2.
DR   AlphaFoldDB; Q9QZT3; -.
DR   SMR; Q9QZT3; -.
DR   STRING; 10116.ENSRNOP00000004237; -.
DR   PaxDb; 10116-ENSRNOP00000004237; -.
DR   GeneID; 29359; -.
DR   KEGG; rno:29359; -.
DR   UCSC; RGD:61935; rat.
DR   AGR; RGD:61935; -.
DR   CTD; 8399; -.
DR   RGD; 61935; Pla2g10.
DR   eggNOG; KOG4087; Eukaryota.
DR   InParanoid; Q9QZT3; -.
DR   OrthoDB; 638584at2759; -.
DR   PhylomeDB; Q9QZT3; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-RNO-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-RNO-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-RNO-1483166; Synthesis of PA.
DR   PRO; PR:Q9QZT3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0001669; C:acrosomal vesicle; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0004623; F:phospholipase A2 activity; IDA:RGD.
DR   GO; GO:0004620; F:phospholipase activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IBA:GO_Central.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISO:RGD.
DR   GO; GO:0043249; P:erythrocyte maturation; ISO:RGD.
DR   GO; GO:0009566; P:fertilization; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0036335; P:intestinal stem cell homeostasis; ISO:RGD.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0051977; P:lysophospholipid transport; ISO:RGD.
DR   GO; GO:0042116; P:macrophage activation; ISO:RGD.
DR   GO; GO:0090370; P:negative regulation of cholesterol efflux; ISO:RGD.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0046473; P:phosphatidic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISO:RGD.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; ISS:UniProtKB.
DR   GO; GO:0046337; P:phosphatidylethanolamine metabolic process; ISS:UniProtKB.
DR   GO; GO:0046471; P:phosphatidylglycerol metabolic process; ISS:UniProtKB.
DR   GO; GO:0006658; P:phosphatidylserine metabolic process; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISO:RGD.
DR   GO; GO:0062234; P:platelet activating factor catabolic process; ISS:UniProtKB.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; ISS:UniProtKB.
DR   GO; GO:0090238; P:positive regulation of arachidonic acid secretion; ISO:RGD.
DR   GO; GO:0010884; P:positive regulation of lipid storage; ISO:RGD.
DR   GO; GO:0032308; P:positive regulation of prostaglandin secretion; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0002532; P:production of molecular mediator involved in inflammatory response; ISO:RGD.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISO:RGD.
DR   GO; GO:0043030; P:regulation of macrophage activation; ISO:RGD.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; Phospholipase A2 domain; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716:SF4; GROUP 10 SECRETORY PHOSPHOLIPASE A2; 1.
DR   PANTHER; PTHR11716; PHOSPHOLIPASE A2 FAMILY MEMBER; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; Phospholipase A2, PLA2; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cleavage on pair of basic residues; Cytoplasmic vesicle;
KW   Disulfide bond; Hydrolase; Lipid metabolism; Lysosome; Metal-binding;
KW   Phospholipid metabolism; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000250"
FT   PROPEP          18..28
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000022768"
FT   CHAIN           29..151
FT                   /note="Group 10 secretory phospholipase A2"
FT                   /id="PRO_0000022769"
FT   ACT_SITE        74
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   ACT_SITE        119
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   BINDING         54
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         56
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   BINDING         58
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   BINDING         75
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        39..97
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        53..143
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        55..71
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        70..125
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        76..150
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        77..118
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        86..111
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
FT   DISULFID        104..116
FT                   /evidence="ECO:0000250|UniProtKB:O15496"
SQ   SEQUENCE   151 AA;  17088 MW;  2581E1520A455089 CRC64;
     MLLLLLLLLL GPGSCLSEAT RRSHVYKRGL LELAGTLDCV GPRSPMAYMN YGCYCGLGGH
     GEPRDAIDWC CYYHDCCYSQ AQDAGCSPKL YRYPWKCMDH RILCGPAENK CQELLCRCDE
     TLAYCLADTE YHLKYLFFPS VLCEKDSPKC N
//
